179 related articles for article (PubMed ID: 10588331)
1. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
Miller RL; Imbertson LM; Reiter MJ; Gerster JF
Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331
[TBL] [Abstract][Full Text] [Related]
2. Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.
Bernstein DI; Miller RL; Harrison CJ
Antiviral Res; 1993 Jan; 20(1):45-55. PubMed ID: 8457147
[TBL] [Abstract][Full Text] [Related]
3. Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.
Harrison CJ; Miller RL; Bernstein DI
Vaccine; 2001 Feb; 19(13-14):1820-6. PubMed ID: 11166907
[TBL] [Abstract][Full Text] [Related]
4. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs.
Harrison CJ; Miller RL; Bernstein DI
Antimicrob Agents Chemother; 1994 Sep; 38(9):2059-64. PubMed ID: 7811019
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation as a treatment strategy for genital herpes: review of the evidence.
Miller RL; Tomai MA; Harrison CJ; Bernstein DI
Int Immunopharmacol; 2002 Mar; 2(4):443-51. PubMed ID: 11962724
[TBL] [Abstract][Full Text] [Related]
6. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
[TBL] [Abstract][Full Text] [Related]
7. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
8. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
Abbo L; Vincek V; Dickinson G; Shrestha N; Doblecki S; Haslett PA
Clin Infect Dis; 2007 Feb; 44(3):e25-7. PubMed ID: 17205432
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
10. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs.
Nakano M; Kurokawa M; Hozumi T; Saito A; Ida M; Morohashi M; Namba T; Kawana T; Shiraki K
Antiviral Res; 1998 Jul; 39(1):25-33. PubMed ID: 9754947
[TBL] [Abstract][Full Text] [Related]
11. Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.
Harrison CJ; Stanberry LR; Bernstein DI
Antiviral Res; 1991 May; 15(4):315-22. PubMed ID: 1659313
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
Bernstein DI; Miller RL; Harrison CJ
J Infect Dis; 1993 Mar; 167(3):731-5. PubMed ID: 8382722
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections.
Sheridan J; Kern E; Martin A; Booth A
Antiviral Res; 1997 Dec; 36(3):157-66. PubMed ID: 9477116
[TBL] [Abstract][Full Text] [Related]
15. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
16. Neonatal herpes simplex virus infection: pathogenesis and treatment in the guinea pig.
Bravo FJ; Myers MG; Stanberry LR
J Infect Dis; 1994 May; 169(5):947-55. PubMed ID: 8169425
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic perianal herpes successfully treated with imiquimod.
Lestre SI; João A; Carvalho C; Serrão VV
An Bras Dermatol; 2011; 86(6):1185-8. PubMed ID: 22281910
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
Bernstein DI; Bravo FJ; Pullum DA; Shen H; Wang M; Rahman A; Glazer RI; Cardin RD
Antivir Chem Chemother; 2015 Feb; 24(1):19-27. PubMed ID: 26149263
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.
Valencia F; Veselenak RL; Bourne N
Methods Mol Biol; 2013; 1030():315-26. PubMed ID: 23821278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
